TP53 and small cell lung carcinoma: Both SCLC transformed samples harboured an activating mutation in PIK3CA, which we previously observed in SCLC transformed cases7 as well as loss of heterozygosity and an inactivating mutation of TP53, which is universally altered in classical SCLC24, 25 (Fig. 3b).